Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Wanhong Xu, PHD
CONTACT
Yilong Wu, MD
CONTACT
Lead
Hangzhou ACEA Pharmaceutical Research Co., Ltd.
With
This is a randomized controlled, double-blind, multicenter, phase III clinical study to compare efficacy and safety of Abivertinib maleate versus first-line standard therapy EGFR-TKI for the treatment of patients with advanced non-small cell lung cancer with sensitive EGFR mutation
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted